Peptides · Peptide comparison
Nisin vs Thymosin Alpha-1
FDA GRAS-approved lantibiotic (34 amino acids) produced by Lactococcus lactis with a dual antimicrobial mechanism — binds lipid II to block cell wall synthesis AND forms 2 nm transmembrane pores for rapid bacterial killing at MIC 0.5-4 μg/mL against gram-positive pathogens including MRSA and Listeria monocytogenes — the only antimicrobial peptide with over 50 years of documented safe human consumption
Your immune system's master trainer—a naturally occurring thymus peptide that wakes up tired immune cells, helps your body fight infections, and keeps your defenses sharp as you age.
- Immune
- Immune
At a glance
Quick comparison
Efficacy
Benefit ratings
Immune
Healing & Recovery
Anti-Aging
Immune Activation
Infection Fighting
Immune Balance
Technical data
Compound specifications
Nisin
- Molecular formula
- C143H230N42O37S7
- Molecular weight
- 3,354.12 Da
- Half-life
- Rapidly degraded in GI tract by digestive proteases; stable for hours to days in food matrices at acidic pH; lanthionine ring structures resist most environmental proteases; thermostable (survives pasteurization)
- Bioavailability
- Degraded by pancreatic proteases in GI tract (does not affect gut microbiome at dietary levels); topical application achieves effective local concentrations; optimal activity at pH 2-6; lanthionine bridges provide significant protease resistance compared to linear peptides
- CAS number
- 1414-45-5
Thymosin Alpha-1
- Molecular formula
- C129H215N33O55
- Molecular weight
- 3108.32 g/mol
- Half-life
- Approximately 2 hours
- Bioavailability
- High when injected subcutaneously (rapid absorption, peak at ~2 hours)
- CAS number
- 62304-98-7
Protocols
Dosing compared
Nisin
Topical
- 10-50 mcg/mL applied to the affected areaOnce or twice daily · Research protocol-dependent (typically 1-4 weeks)Topical antimicrobial concentration range used in wound-care and infection-control research [5]. Investigational; not an approved human therapeutic route.
Thymosin Alpha-1
Subcutaneous injection
- 1.6 mgTwice weekly (3-4 days apart) · 6-12 monthsEstablished clinical dose for thymalfasin (Zadaxin); body-surface-scaled as 900 mcg/m2 [4][6]. Phase III chronic hepatitis B trials used 1.6 mg SC twice weekly for 6-12 months [4].
- 1.6 mg daily, then 1.6 mg twice weeklyDaily for an initial loading period, then twice weekly · 12+ weeksThe schedule used in a randomized trial in HBV-related acute-on-chronic liver failure: 1.6 mg daily for the first week, then twice weekly to week 12 [3].
Applications
Best suited for
Nisin
- Food preservation as a natural antimicrobial alternative to chemical preservatives
- Nisin is particularly well-suited for individuals focused on food preservation as a natural antimicrobial alternative to chemical preservatives. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Research into novel antimicrobial therapeutics based on lantibiotic scaffolds
- Nisin is particularly well-suited for individuals focused on research into novel antimicrobial therapeutics based on lantibiotic scaffolds. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Anti-Listeria and anti-Clostridium strategies in food safety and clinical settings
- Nisin is particularly well-suited for individuals focused on anti-listeria and anti-clostridium strategies in food safety and clinical settings. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Development of antimicrobial wound dressings and dental applications
- Nisin is particularly well-suited for individuals focused on development of antimicrobial wound dressings and dental applications. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Thymosin Alpha-1
- Chronic Hepatitis B or C Support
- Thymosin Alpha-1 has its strongest clinical evidence here. Multiple trials show it helps clear viral loads and normalize liver enzymes, especially when combined with antiviral medications. It's approved in over 30 countries specifically for hepatitis treatment.
- Cancer Treatment Support
- When used alongside chemotherapy, Thymosin Alpha-1 may help maintain immune function that chemo tends to suppress. Research in lung cancer, melanoma, and liver cancer shows improved outcomes when added to standard treatments. It helps your immune system keep fighting even during tough treatments.
- Age-Related Immune Decline
- As you age, your thymus shrinks and produces less thymosin naturally—a process called immunosenescence. Supplementing with Thymosin Alpha-1 may help compensate, keeping your immune defenses more youthful and responsive. Think of it as replacing what your body makes less of over time.
- Severe Infection Recovery
- In sepsis and critical infections, Thymosin Alpha-1 has shown promise for reducing mortality by helping restore immune balance. It's particularly interesting because it modulates immunity rather than just boosting it—calming overreaction while enhancing pathogen-fighting ability.
Safety profile
Side effects
Nisin
Common
- No significant effects at dietary levels
- Mild GI discomfort at research doses
- Local irritation (topical use)
Uncommon
- Milk protein allergic reaction
- Gram-negative overgrowth
Serious
- No documented serious adverse effects
Thymosin Alpha-1
Common
- Injection site reactions
Uncommon
- Mild fatigue
- Flu-like symptoms
- Mild fever
- Lymph node awareness
Serious
- Allergic reaction
Research status
Safety & evidence
Nisin
- Evidence level
- Strong human trials (Phase 3 or FDA approved)
- FDA status
- Not an FDA-approved drug. Nisin preparation is affirmed as GRAS (21 CFR 184.1538, 1988) only as a food antimicrobial, for example to inhibit Clostridium botulinum in pasteurized cheese spreads; therapeutic uses are investigational.
- Safety overview
- Nisin holds FDA GRAS status since 1988 with over 50 years of documented safe human consumption, making it the only antimicrobial peptide with this comprehensive long-term safety record. Oral LD50 of 174 mg/kg in mice (comparable to table salt) demonstrates extraordinary safety margin. Acceptable daily intake established at 0.13 mg/kg body weight with no reported serious adverse events at this or higher levels. Primary risk is milk protein contamination during production, requiring screening for lactose-intolerant or milk-allergic individuals.
Contraindications
- Known hypersensitivity to nisin or Lactococcus lactis-derived products
- Milk protein allergy — nisin production involves dairy-associated bacteria and preparations may contain trace milk proteins
- Pregnancy and breastfeeding at therapeutic (non-dietary) doses — standard dietary exposure through preserved foods is considered safe
- Active inflammatory bowel disease — potential for local irritation at high oral concentrations exceeding normal dietary levels
Thymosin Alpha-1
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Not FDA approved. There is no thymalfasin application in Drugs@FDA. It is used outside the US (as Zadaxin) for chronic hepatitis B and as an immune adjuvant.
- Safety overview
- Thymosin Alpha-1 has one of the most extensive safety records of any peptide, with decades of clinical use across multiple countries. Studies consistently report minimal side effects—mostly limited to mild injection site reactions. The 2-hour half-life means it doesn't accumulate in your system. It's been used safely in thousands of patients with hepatitis, cancer, and other serious conditions.
Contraindications
- Organ transplant recipients on immunosuppressants
- Active autoimmune disease flares
- Known allergy to thymosin peptides
- Pregnancy or breastfeeding
- Children under 18 without medical supervision
Decision guide
Which is right for you?
Nisin
Choose Nisin if…
- Food preservation as a natural antimicrobial alternative to chemical preservatives
- Research into novel antimicrobial therapeutics based on lantibiotic scaffolds
- Anti-Listeria and anti-Clostridium strategies in food safety and clinical settings
- Development of antimicrobial wound dressings and dental applications
Thymosin Alpha-1
Choose Thymosin Alpha-1 if…
- Immune system strengthening
- Chronic infection support
- Cancer adjunct therapy
- Healthy aging immune support